Abstract:Background: As cancer metastasis is the deadliest aspect of cancer, causing 90% of human deaths, evaluating the molecular mechanisms underlying this process is the major interest to those in the drug development field. Both therapeutic target identification and proof-of-concept experimentation in anti-cancer drug development require appropriate animal models, such as xenograft tumor transplantation in transgenic and knockout mice. In the progression of cancer metastasis, circulating tumor cells (CTCs) are the most critical factor in determining the prognosis of cancer patients. Several studies have demonstrated that measuring CTC-specific markers in a clinical setting (e.g., flow cytometry) can provide a current status of cancer development in patients. However, this useful technique has rarely been applied in the real-time monitoring of CTCs in preclinical animal models. Methods: In this study, we designed a rapid and reliable detection method by combining a bioluminescent in vivo imaging system (IVIS) and quantitative polymerase chain reaction (QPCR)-based analysis to measure CTCs in animal blood. Using the IVIS Spectrum CT System with 3D-imaging on orthotropic-developed breast-tumor-bearing mice. Results: In this manuscript, we established a quick and reliable method for measuring CTCs in a preclinical animal mode. The key to this technique is the use of specific human and mouse GUS primers on DNA/RNA of mouse peripheral blood under an absolute qPCR system. First, the high sensitivity of cancer cell detection on IVIS was presented by measuring the luciferase carried MDA-MB-231 cells from 5 to 5x1011 cell numbers with great correlation (R2 = 0.999). Next, the MDA-MB-231 cell numbers injected by tail vein and their IVIS radiance signals were strongly corrected with qPCR-calculated copy numbers (R2 > 0.99). Furthermore, by applying an orthotropic implantation animal model, we successfully distinguished xenograft tumor-bearing mice and control mice with a significant difference (p < 0.001), whereas IVIS Spectrum-CT 3D-visualization showed that blood of mice with lung metastasis contained more than twice the CTC numbers than ordinary tumor-bearing mice. We demonstrated a positive correlation between lung metastasis status and CTC numbers in peripheral mouse blood. Conclusion: Collectively, the techniques developed for this study resulted in the integration of CTC assessments into preclinical models both in vivo and ex vivo, which will facilitate translational targeted therapy in clinical practice.

Real‐time monitoring of single circulating tumor cells with a fluorescently labeled deoxy‐glucose by in vivo flow cytometry

Monitoring circulating tumor cells in vivo by a confocal microscopy system

Biofluorescence imaging-guided spatial metabolic tracing: In vivo tracking of metabolic activity in circulating tumor cell-mediated multi-organ metastases

A Noninvasive and Real-Time Method for Circulating Tumor Cell Detection by In Vivo Flow Cytometry.

A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model

Metabolic Glycoengineering-Programmed Nondestructive Capture of Circulating Tumor Cells.

Imaging Cellular Aerobic Glycolysis using Carbon Dots for Early Warning of Tumorigenesis

Time-gated Luminescence Imaging for Background Free in Vivo Tracking of Single Circulating Tumor Cells.

Nanosphere-based One-Step Strategy for Efficient and Nondestructive Detection of Circulating Tumor Cells.

Single-Cell Codetection of Metabolic Activity, Intracellular Functional Proteins, and Genetic Mutations from Rare Circulating Tumor Cells

An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer

Ex Vivo and in Vivo Capture and Deactivation of Circulating Tumor Cells by Dual-Antibody-coated Nanomaterials.

In Vivo Coinstantaneous Identification of Hepatocellular Carcinoma Circulating Tumor Cells by Dual-Targeting Magnetic-Fluorescent Nanobeads

Beyond enumeration: Phenotype independent “labeling-capture-release” process enabling precise detection of circulating tumour cells and downstream applications

P2.01-001 Enrichment-Free, Rapid Metabolic Assay for Detection of Tumor Cells in Pleural Effusion and Pheripheral Blood: Topic: Analysis of Body Fluids in Cancer

In Vivo Flow Cytometry: A New Method for Monitoring Circulating Cancer Cells

Highly Specific and Sensitive Point-of-care Detection of Rare Circulating Tumor Cells in Whole Blood Via a Dual Recognition Strategy.

In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen

Metabolism-Based Capture and Analysis of Circulating Tumor Cells in an Open Space.

Real-time detection of circulating tumor cells in living animals using functionalized large gold nanorods

Detection of Circulating Tumor Cells by Fluorescence Microspheres-Mediated Amplification